Quality of life in patients with inflammatory bowel disease: Importance of clinical, demographic and psychosocial factors;Qualidade de vida dos doentes com doença inflamatória intestinal: Importância dos fatores clínicos, demográficos e sociais

Arquivos de Gastroenterologia

Volumn 51, Issue 3, 2014, Pages 192-197

  Magalhães, Joana ^a   de Castro, Francisca Dias ^a   Carvalho, Pedro Boal ^a   Leite, Sílvia ^a   Moreira, Maria João ^a   Cotter, José ^a,b,c  

^a Centro Hospital Alto Ave EPE   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Crohn disease; Inflammatory bowel diseases; Quality of life; Questionnaires; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; STEROID;

ABDOMINAL DISTENSION; ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; ASSESSMENT OF HUMANS; CAREER; CLINICAL FEATURE; DEPRESSION; EDUCATION; FATIGUE; FEMALE; FRUSTRATION; GENDER; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 32; LEISURE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SMOKING; SOCIAL PSYCHOLOGY; WORKPLACE; CROHN DISEASE; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; SOCIAL SUPPORT; SOCIOECONOMICS; ULCERATIVE COLITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84925226592     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032014000300005     Document Type: Article

References (49)

1. Ananthakrishnan AN, Korzenik JR, Hur C. Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis. 2013;19:37-44.
2. Ananthakrishnan AN, Weber LR, Knox JF, Skaros S, Emmons J, Lundeen S, et al. Permanent work disability in Crohn's disease. Am J Gastroenterol. 2008;103: 154-61.
3. Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:402-12.
4. Bernstein CN, Kraut A, Blanchard JF, Rawsthorne P, Yu N, Walld R. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol. 2001;96:2117-25.
5. Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol. 2001;96:2915-20.
6. Boonen A, Dagnelie PC, Feleus A, Hesselink MA, Muris JW, Stockbrügger RW, et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis. 2002; 8:382-9.
7. Burisch J, Jess T, Martinato M, Lakatos PL; ECCO-EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7:322-37.
8. Casati J, Toner BB, De Rooy EC, Drossman DA, Maunder RG. Concerns of Patients with Inflammatory Bowel Disease: A Review of Emerging Themes. Dig Dis Sci. 2000;45:26-31.
9. Casellas F, López-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol. 2000;95:177-82.
10. Casellas F, López-Vivancos J, Sampedro M, Malagelada JR. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol. 2005;100:2737-42.
11. Casellas F, Robles V, Borruel N, Torrejón A, Castells I, Navarro E, et al. Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment. J Crohns Colitis. 2012;6:881-6.
12. Castillo-Cejas MD, Robles V, Borruel N, Torrejón A, Navarro E, Peláez A, et al. Questionnaries for measuring fatigue and its impact on health perception in inflammatory bowel disease. Rev Esp Enferm Dig. 2013;105:144-53.
13. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther. 2002;16:1603-9.
14. Czuber-Dochan W, Ream E, Norton C. Description and management of fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:505-16.
15. Dowdy SW, Dwyer KA, Smith CA, Wallston KA. Gender and psychological well-being of persons with rheumatoid arthritis. Arthritis Care Res. 1996;9:449-56.
16. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006,12:38-46.
17. Feagan BG, Bala M, Yan S, Olson A, Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol. 2005;39:390-5.
18. Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR. The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol. 2003;98:2232-8.
19. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-10.
20. Høivik ML, Moum B, Solberg IC, Henriksen M, Cvancarova M, Bernklev T. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut. 2013;62:368-75.
21. Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011;17:1564-72.
22. Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:106-14.
23. Kemp K, Griffiths J, Lovell K. Understanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence. World J Gastroenterol. 2012,18:6240-9.
24. Larsson K, Lööf L, Rönnblom A, Nordin K. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008;64:139-48.
25. Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, et al. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008;103:3132-41.
26. Louis E, Löfberg R, Reinisch W, Camez A, Yang M, Pollack PF, et al. Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial. J Crohns Colitis. 2013;7:34-43.
27. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992;14:15-9.
28. Maunder R, Toner B, de Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol. 1999;13:728-32.
29. Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013;7:467-73.
30. Moreno-Jiménez B, Blanco BL, Rodríguez-Muñoz A, Garrosa Hernández E. The influence of personality factors on health-related quality of life of patients with inflammatory bowel disease. J Psychosom Res. 2007;62:39-46.
31. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7:853-8.
32. Moskovitz DN, Maunder RG, Cohen Z, McLeod RS, MacRae H. Coping behavior and social support contribute independently to quality of life after surgery for inflammatory bowel disease. Dis Colon Rectum. 2000;43:517-21.
33. Oliveira S, Zaltman C, Elia C, Vargens R, Leal A, Barros R, et al. Quality-of-life measurement in patients with inflammatory bowel disease receiving social support. Inflamm Bowel Dis. 2007;13:470-4.
34. Petterson T, Lee P, Hollis S, Young B, Newton P, Dornan T. Well-being and treatment satisfaction in older people with diabetes. Diabetes Care. 1998;21:930-5.
35. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105:289-97.
36. Pontes RM, Miszputen SJ, Ferreira-Filho OF, Miranda C, Ferraz MB. Qualidade de Vida em Pacientes Portadores de Doença Inflamatória Intestinal: tradução para português e validação do questionário "Inflammatory Bowel Dosease Questionnaire" (IBDQ). Arq Gastroenterol. 2004;41:137-43.
37. Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychological distress in patients with inflammatory bowel disease. Scand J Gastroenterol. 1996;31:792-6.
38. Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010;16:2137-47.
39. Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology. 1999;117:761-9.
40. Sainsbury A, Heatley RV. Psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:499-508.
41. Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299-310.
42. Sørensen VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with Crohn's disease. Gut. 1987;28:382-5.
43. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724-35.
44. Stjernman H, Tysk C, Almer S, Ström M, Hjortswang H. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol. 2011;23:671-9.
45. van der Have M, van der Aalst KS, Kaptein AA, Leenders M, Siersema PD, Oldenburg B, et al. Determinants of health-related quality of life in Crohn's disease: A systematic review and meta-analysis. J Crohns Colitis. 2014;8:93-106.
46. Van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32:131-43.
47. Verissimo R. Quality of Life in Inflammatory Bowel Disease: Psychometric Evaluation of an IBDQ Cross-Culturally Adapted Version. J Gastrointestin Liver Dis. 2008;17:439-44.
48. Victoria CR, Sassak LY, Nunes HR. Assessment of quality of life of patients with inflammatory bowel disease residing in Southern Brazil. Arq Gastroenterol. 2010;47:285-9.
49. Wijnhoven HAH, Kriegsman DM, Snoek FJ, Hesselink AE, de Haan M. Gender differences in health-related quality of life among asthma patients. J Asthma. 2003;40:189-99.